XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Statement of Changes in Stockholders' Equity - USD ($)
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2022 $ 5 [1] $ 116 [1] $ 145,574,080 [1] $ (122,492,176) $ 23,082,025
Balance (in shares) at Jun. 30, 2022 484,582 11,592,173      
Series A preferred stock issued for employee stock compensation $ 0 $ 0 56,357 0 56,357
Series A preferred stock issued for employee stock compensation (in shares) 13,092 0      
Series A preferred stock issued for license agreement $ 0 $ 0 156,987 0 156,987
Series A Preferred stock issued for license agreement (in shares) 50,000 0      
Common stock issued for consulting and legal services rendered $ 0 $ 1 107,999 0 108,000
Common stock issued for consulting and legal services rendered (in shares) 0 72,668      
Warrants issued to Scientific Advisory Board $ 0 $ 0 1,012 0 1,012
Common stock issued for employee compensation $ 0 $ 0 4,822 0 4,822
Common stock issued for employee compensation (in shares) 0 3,572      
Common stock issued for Directors fees $ 0 $ 0 45,000 0 45,000
Common stock issued for Directors fees (in shares) 0 30,084      
Net Income (Loss) $ 0 $ 0 0 (8,588,573) (8,588,573)
Balance at Jun. 30, 2023 $ 5 $ 117 145,946,257 (131,080,749) 14,865,630
Balance (in shares) at Jun. 30, 2023 547,674 11,698,497      
Series A preferred stock issued for employee stock compensation     43,245   43,245
Series A preferred stock issued for employee stock compensation (in shares) 13,092        
Series A preferred stock issued upon conversion of related party promissory note $ 4 $ 0 1,499,996 0 1,500,000
Series A preferred stock issued upon conversion of related party promissory note (in shares) 331,859 0      
Proceeds from sale of common stock in connection with equity financings   $ 13 3,120,024   3,120,037
Proceeds from sale of common stock in connection with equity financings (in shares)   1,308,651      
Common stock issued for consulting and legal services rendered $ 0 $ 1 131,599 0 131,600
Common stock issued for consulting and legal services rendered (in shares) 0 101,542      
Warrants issued to Scientific Advisory Board $ 0 $ 0 563 0 563
Common stock issued for employee compensation $ 0 $ 0 2,340 0 2,340
Common stock issued for employee compensation (in shares) 0 1,786      
Forgiveness of interest on related party debt $ 0 $ 0 49,808 0 49,808
Common stock issued for Directors fees     45,000   45,000
Common stock issued for Directors fees (in shares)   33,579      
Net Income (Loss)       (8,294,146) (8,294,146)
Balance at Jun. 30, 2024 $ 9 $ 131 $ 150,838,832 $ (139,374,895) $ 11,464,077
Balance (in shares) at Jun. 30, 2024 892,625 13,144,055      
[1] Restated to reflect change in par value upon redomicile (see Note 8)